Approvals
  • Most Popular
  • Latest News
  • Breaking News
  • User Submitted Articles
  • Contribute an Article
  • GlobeNewswire
  • News and Analysis
  • About Us
  • Support
  • McKesson Completes Acquisition of RxCrossroads
    Wednesday, 03 January 2018 03:06
    Jan. 3, 2018 14:00 UTC

    McKesson Completes Acquisition of RxCrossroads

    SAN FRANCISCO--(BUSINESS WIRE)-- McKesson Corporation (NYSE:MCK), a global leader in healthcare supply chain management solutions, announced today that it has completed the previously announced acquisition of RxCrossroads.

    About McKesson Corporation

    McKesson Corporation, currently ranked 5th on the FORTUNE 500, is a global leader in healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology. McKesson partners with pharmaceutical manufacturers, providers, pharmacies, governments and other organizations in healthcare to help provide the right medicines, medical products and healthcare services to the right patients at the right time, safely and cost-effectively. United by our ICARE shared principles, our employees work every day to innovate and deliver opportunities that make our customers and

    partners more successful — all for the better health of patients. McKesson has been named the “Most Admired Company” in the healthcare wholesaler category by FORTUNE, a “Best Place to Work” by the Human Rights Campaign Foundation, and a top military-friendly company by Military Friendly. For more information, visit www.mckesson.com.

    Contacts

    McKesson Corporation
    Investors and

    Error. Page cannot be displayed. Please contact your service provider for more details. (14)

    Financial Media:
    Craig Mercer, 415-983-8391
    Craig.Mercer@mckesson.com


    Source: McKesson Corporation




    BiomedReports is not paid or compensated by newswires to disseminate or report news and developments about publicly traded companies, but may from time to time receive compensation for advertising, data, analytics and investor relation services from various entities and firms. Full disclosures should be read in the 'About Us Section'.

    Add this page to your favorite Social Bookmarking websites
    Digg! Reddit! Del.icio.us! Mixx! Google! Live! Facebook! Technorati! StumbleUpon! MySpace! Yahoo!
     
    BMR:1